Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
What’s Behind Cannabis Stock HERB? (click to learn more) Eshbal Acquires a 55% Interest in Dare to Be Different Foods (click to learn more) CSE: ALEN.U — AI Meets Digital Health (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News CardioGenics Holdings Inc (EM) CGNH

Healthcare Diagnostics & Research Medical Instruments & Supplies
CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay... see more

Recent & Breaking News (EXPM:CGNH)

    UPDATED: CARDIOGENICS HOLDINGS INC. ANNOUNCES A RECORD DATE CHANGE FOR ITS DIVIDEND DISTRIBUTION

    GlobeNewswire September 28, 2021

    CARDIOGENICS HOLDINGS INC. ANNOUNCES A RECORD DATE CHANGE FOR ITS DIVIDEND DISTRIBUTION

    GlobeNewswire September 9, 2021

    CARDIOGENICS HOLDINGS INC. ANNOUNCES LICENSE AGREEMENT AND DIVIDEND DISTRIBUTION

    GlobeNewswire September 3, 2021

    CardioGenics Enters Into Asset Purchase Agreement to Acquire All Assets of Ontario-Based Plasticap

    Marketwired November 4, 2015

    CardioGenics Enters Into Binding Letter of Intent to Acquire Assets of Ontario-Based Plasticap

    Marketwired October 5, 2015

    CardioGenics Enters Into Manufacturing Agreement With Ontario-Based Plasticap

    Marketwired August 25, 2015

    USPTO Issues Notice of Allowance in Connection With CardioGenics' Self-Metering Cartridge Patent Application

    GlobeNewswire February 17, 2015

    CardioGenics Announces Appointment of New Director

    GlobeNewswire January 12, 2015

    CORRECTING AND REPLACING -- CardioGenics Announces $1.3 Million Private Placement to European Investors

    GlobeNewswire June 12, 2014

    CardioGenics Announces $1.3 Million Private Placement to European Investors

    GlobeNewswire June 12, 2014

    Hot Gold and Tech Plays in the Micro and Small Cap Markets

    Marketwired September 30, 2013

    Small-Cap Specialists Issues New Research Report With Stocks on Watch

    Marketwired August 26, 2013

    CardioGenics Announces Commencement of Beta-Site Testing

    Globe Newswire August 21, 2013

    CardioGenics Announces Schedule for Beta-Site Testing

    Globe Newswire July 10, 2013

    CardioGenics Announces Internal Review Board Approval for Beta-Site Testing

    PR Newswire June 5, 2013

      Podcasts